Level Four Advisory Services, LLC Novartis Ag Transaction History

Level Four Advisory Services, LLC

$2.3 Billion
Q3 2024

A detailed history of Level Four Advisory Services, LLC transactions in Novartis Ag stock. As of the latest transaction made, Level Four Advisory Services, LLC holds 9,979 shares of NVS stock, worth $1.03 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

9,979

Previous 10,829 7.85%

Holding current value

$1.03 Million

Previous $1.15 Million 0.43%

% of portfolio

0.05%

Previous 0.05%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$106.13 - $120.89 $90,210 - $102,756	-850 Reduced 7.85%	9,979 $1.15 Million
Q2 2024 Aug 09, 2024	SELL	$92.57 - $107.37 $69,797 - $80,956	-754 Reduced 6.51%	10,829 $1.15 Million
Q1 2024 May 13, 2024	BUY	$95.27 - $108.47 $18,291 - $20,826	192 Added 1.69%	11,583 $1.12 Million
Q4 2023 Feb 08, 2024	SELL	$92.27 - $101.54 $65,419 - $71,991	-709 Reduced 5.86%	11,391 $1.15 Million
Q3 2023 Nov 13, 2023	SELL	$94.73 - $105.13 $78,246 - $86,837	-826 Reduced 6.39%	12,100 $1.23 Million
Q2 2023 Jul 10, 2023	BUY	$92.52 - $104.91 $170,051 - $192,824	1,838 Added 16.58%	12,926 $1.3 Million
Q1 2023 Jun 05, 2023	BUY	$80.03 - $92.81 $175,825 - $203,903	2,197 Added 24.71%	11,088 $1.02 Million
Q4 2022 Feb 13, 2023	SELL	$75.55 - $92.52 $203,985 - $249,804	-2,700 Reduced 23.29%	8,891 $806,000
Q3 2022 Nov 07, 2022	SELL	$74.61 - $87.26 $33,425 - $39,092	-448 Reduced 3.72%	11,591 $881,000
Q2 2022 Aug 08, 2022	SELL	$80.52 - $93.75 $122,873 - $143,062	-1,526 Reduced 11.25%	12,039 $1.02 Million
Q1 2022 May 10, 2022	BUY	$80.11 - $90.62 $408,801 - $462,433	5,103 Added 60.3%	13,565 $1.19 Million
Q4 2021 Feb 11, 2022	SELL	$79.7 - $88.13 $201,083 - $222,351	-2,523 Reduced 22.97%	8,462 $740,000
Q3 2021 Oct 12, 2021	BUY	$81.78 - $95.14 $644,589 - $749,893	7,882 Added 254.01%	10,985 $898,000
Q2 2021 Aug 09, 2021	BUY	$85.24 - $94.15 $6,137 - $6,778	72 Added 2.38%	3,103 $283,000
Q1 2021 May 10, 2021	SELL	$83.5 - $98.47 $37,575 - $44,311	-450 Reduced 12.93%	3,031 $259,000
Q4 2020 Feb 10, 2021	SELL	$78.07 - $94.43 $8,431 - $10,198	-108 Reduced 3.01%	3,481 $329,000
Q3 2020 Nov 02, 2020	SELL	$82.14 - $91.0 $63,740 - $70,616	-776 Reduced 17.78%	3,589 $312,000
Q2 2020 Aug 17, 2020	BUY	$80.93 - $91.1 $353,259 - $397,651	4,365 New	4,365 $380,000
Q2 2020 Jul 27, 2020	SELL	$80.93 - $91.1 $329,223 - $370,594	-4,068 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$70.67 - $99.01 $12,225 - $17,128	173 Added 4.44%	4,068 $332,000
Q4 2019 Feb 13, 2020	BUY	$84.35 - $95.37 $22,943 - $25,940	272 Added 7.51%	3,895 $392,000
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $9,751 - $10,745	-114 Reduced 3.05%	3,623 $315,000
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $15,155 - $18,652	201 Added 5.68%	3,737 $341,000
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $11,674 - $13,353	-155 Reduced 4.2%	3,536 $340,000
Q4 2018 Feb 08, 2019	BUY	$73.66 - $82.02 $64,452 - $71,767	875 Added 31.07%	3,691 $317,000
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $20,751 - $24,003	-310 Reduced 9.92%	2,816 $243,000
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $5,257 - $5,942	-81 Reduced 2.53%	3,126 $236,000
Q1 2018 May 14, 2018	SELL	$70.39 - $84.15 $22,032 - $26,338	-313 Reduced 8.89%	3,207 $259,000
Q4 2017 Feb 13, 2018	SELL	$72.33 - $77.64 $1.03 Million - $1.11 Million	-14,250 Reduced 80.19%	3,520 $296,000
Q3 2017 Apr 03, 2018	SELL	$74.14 - $77.27 $3,113 - $3,245	-42 Reduced 0.24%	17,770 $1.53 Million
Q3 2017 Nov 15, 2017	BUY	$74.14 - $77.27 $805,975 - $840,002	10,871 Added 156.62%	17,812 $1.53 Million
Q2 2017 Sep 20, 2017	SELL	N/A	-3,542 Reduced 33.79%	6,941 $512,000
Q1 2017 Sep 20, 2017	BUY	N/A	10,483	10,483 $775,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Level Four Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Level Four Advisory Services, LLC with notifications on news.

Account

Level Four Advisory Services, LLC Novartis Ag Transaction History